Fungal Toenail Onychomycosis Treatment 2026 | DPM

Onychomycosis (fungal toenail infection) is caused by dermatophyte fungi in approximately 90% of cases -- most commonly Trichophyton rubrum -- with non-dermatophyte molds and Candida yeasts responsible for the remainder; the infection occurs when fungi breach the normal nail defenses and establish a colony within the nail plate and nail bed. The causative organisms: dermatophytes (the most common -- 90%): Trichophyton rubrum: the most common cause of onychomycosis worldwide; can infect nails for decades without symptoms other than nail discoloration; Trichophyton mentagrophytes: associated with white superficial onychomycosis; non-dermatophyte molds: Fusarium, Aspergillus, Scopulariopsis -- more common in tropical regions and in immunocompromised patients; Candida: typically affects fingernails more than toenails; associated with chronic wet hand exposure; How the infection enters: the nail acts as a physical barrier; infection occurs when this barrier is breached: nail trauma (direct injury, repeated microtrauma from tight shoes); fungal nail infections most commonly develop in association with tinea pedis (athlete's foot) -- the dermatophyte infects the skin between the toes first, then migrates to the nail; the proximal nail fold can serve as an entry point; Risk factors: prior tinea pedis infection (the single biggest risk factor); older age (the nail grows more slowly with age, giving fungi more time to establish); diabetes (impaired immunity and peripheral circulation); peripheral vascular disease; immunosuppression (from medications or HIV); communal bathing areas (swimming pools, locker rooms, gym showers); tight or occlusive footwear; nail trauma; family history (genetic susceptibility); hyperhidrosis (moist feet support fungal growth); the toenails are affected far more commonly than fingernails because the foot environment (warm, moist, inside a shoe) is optimal for dermatophyte growth.

Onychomycosis treatment requires months of antifungal therapy -- the nail must grow out completely (6-12 months for toenails) before a cure is confirmed; oral antifungals are significantly more effective than topical agents for most presentations. Oral antifungal therapy (the most effective treatment): terbinafine (Lamisil) -- the gold standard: cure rate for onychomycosis: 60-70% mycological cure, 35-50% complete clinical cure at 1 year; mechanism: inhibits fungal squalene epoxidase, disrupting ergosterol synthesis; dose: 250mg daily for 12 weeks for toenails (6 weeks for fingernails); accumulates in the nail plate and remains active for months after the course ends; liver function monitoring: recommended before and during treatment in patients with liver disease history; drug interactions: CYP2D6 and CYP3A4 interactions with common medications; itraconazole (Sporanox): alternative for patients who cannot take terbinafine; pulse dosing (400mg daily for 1 week per month for 3 months) or continuous dosing; slightly lower cure rates than terbinafine for dermatophytes; topical antifungal therapy: efinaconazole (Jublia): the most effective topical antifungal for onychomycosis; cure rate: approximately 15-18% complete cure at 52 weeks; applied to the nail daily for 48 weeks; does not require liver monitoring; appropriate for mild disease (less than 50% nail involvement, no matrix involvement) or patients who cannot take oral therapy; tavaborole (Kerydin): similar efficacy to efinaconazole; ciclopirox (Penlac) nail lacquer: older topical agent; lower cure rate (5-8%) but very low side effect profile; combination therapy: combining oral terbinafine with efinaconazole improves cure rates above either alone; device-based treatments: laser therapy for onychomycosis (Nd:YAG, CO2 laser): FDA-cleared; evidence for effectiveness is limited and inconsistent; the FDA clearance is for temporary clearing of the nail, not for cure; surgical nail removal combined with antifungal therapy improves penetration.

Onychomycosis has characteristic clinical appearances that are recognized by podiatrists and dermatologists -- but because several other nail conditions can mimic the appearance of fungal infection, laboratory confirmation before treatment is important. The clinical presentation of onychomycosis: distal lateral subungual onychomycosis (the most common pattern -- 85% of cases): infection begins at the distal (free) edge of the nail; the nail becomes yellow, brown, or white; the nail thickens as the fungal debris accumulates beneath the nail plate (subungual hyperkeratosis); the nail becomes brittle, crumbly, and may separate from the nail bed (onycholysis); the infection progresses proximally over months to years; white superficial onychomycosis: white patches appear on the surface of the nail plate; the nail surface is chalky and easily scraped off; caused by T. mentagrophytes; proximal subungual onychomycosis: infection begins at the proximal nail fold; rare; associated with immunosuppression; Conditions that mimic onychomycosis: psoriatic nail disease: pitting, onycholysis, oil spots, and nail thickening from psoriasis; requires dermatology evaluation; trauma (nail dystrophy): chronic trauma from ill-fitting shoes produces thickened, discolored nails that are clinically indistinguishable from onychomycosis; lichen planus of the nail; yellow nail syndrome; Laboratory confirmation before treatment: the importance: treating non-fungal nail disease with antifungals is both ineffective and exposes the patient to unnecessary medication risks; methods: KOH microscopy: a nail clipping is dissolved in potassium hydroxide; the fungal hyphae are visible microscopically; sensitivity approximately 65-85%; fungal culture: nail clippings or subungual debris are cultured on Sabouraud's agar; confirms the species but takes 2-4 weeks; PAS stain histology: nail biopsy or clipping sent to pathology; the most sensitive method; fungal elements stain red; PCR testing: rapid, highly sensitive molecular testing for fungal DNA; the podiatrist's confirmation workflow: clinical assessment + KOH prep + culture (or PCR) before prescribing oral antifungals.

Yes -- onychomycosis can spread to other parts of the body, and it frequently acts as a reservoir for recurrent tinea pedis (athlete's foot); understanding the transmission patterns helps patients prevent spread and recurrence. Spread from toenails to the skin: tinea pedis (athlete's foot): the most common form of spread; the same dermatophyte that infects the nail can colonize the adjacent skin between the toes and on the plantar foot; the skin infection (tinea pedis) may have preceded the nail infection (toenails develop onychomycosis from preexisting tinea pedis) or may develop from an established nail reservoir; the nail acts as a permanent reservoir of fungi that continuously seeds the adjacent skin, making it very difficult to eliminate tinea pedis without also treating the nail infection; tinea cruris (jock itch): the dermatophyte can spread from the feet to the groin area via contaminated hands, towels, or from pulling underwear over infected feet; tinea corporis (ringworm of the body): the fungus can infect any skin surface; Spread between individuals: direct contact: sharing footwear, socks, or towels; indirect contact: contaminated floors in communal changing areas, showers, and locker rooms; the family unit: spouses and family members of patients with onychomycosis are at significantly higher risk; household carpets and bathroom floors can harbor fungi; Spread from skin to nails: onychomycosis is most commonly acquired from preexisting tinea pedis; treating tinea pedis without treating the nail infection results in rapid skin recurrence; Prevention of spread: complete treatment of both nail and skin fungal infections simultaneously; use of antimicrobial washes in communal areas; wearing footwear in shared bathing facilities; treating household contacts who have tinea pedis to break the household transmission cycle; using antifungal powder in shoes during and after treatment; nail hygiene: keep nails trimmed short; the importance of treating the nails: even when tinea pedis appears to resolve, an untreated fungal nail will reliably re-seed the skin, causing recurrent athlete's foot; eradicating the nail reservoir is essential for lasting skin clearance.